The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer
Identification of Paraneoplastic and Intratumor Microplastics in Gastric Cancer and Their Association Analysis With Macrogenomics and Metabolomics
1 other identifier
observational
20
1 country
1
Brief Summary
The aim of this study was to identify and quantify microplastics in blood, stool, and tumor surgical specimens from gastric cancer patients by analyzing the nature, type, and abundance of microplastics using laser direct infrared (LDIR) spectroscopy, scanning electron microscopy (SEM), and pyrolysis-gas chromatography-mass spectrometry (Py-GC/MS). Meanwhile, combining macro-genomic and metabolomic techniques to explore the association between microplastics and host microbiota and metabolic profiles, and to reveal the potential effects of microplastics on gastric cancer incidence and development will provide new insights into the relationship between microplastic contamination and gastric cancer, as well as an important scientific basis for future public health strategies and cancer prevention and control measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 25, 2025
CompletedFirst Posted
Study publicly available on registry
March 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 4, 2025
February 1, 2025
2.1 years
February 25, 2025
February 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Types of microplastics in gastric cancerous and paracancerous tissues (categorical measure)
Polymer types of microplastics in gastric tissues Time Frame: Intraoperative sampling Measuring tool: μ-FTIR spectroscopy Unit: Categorical classification (e.g., polyethylene, polypropylene, etc.)
The date of microplastics testing, assessed up to 1 week after surgery.
Secondary Outcomes (2)
Physical-chemical properties of microplastics in gastric cancerous and paracancerous tissues (continuous measure)
The date of microplastics testing, assessed up to 1 week after surgery.
Abundance of microplastics in gastric cancerous and paracancerous tissues (count/particles per gram)
The date of microplastics testing, assessed up to 1 week after surgery.
Study Arms (1)
the gastric cancer group
patients diagnosed with gastric cancer
Interventions
Patients diagnosed with gastric cancer by pathological biopsy.
Eligibility Criteria
Patients diagnosed with colorectal cancer by pathological biopsy were included in the study.
You may qualify if:
- age ≥18 years old;
- diagnosed with gastric cancer by pathology before surgery and not receiving chemotherapy, radiotherapy or immunotherapy;
- no history of other gastrointestinal diseases;
- complete clinical data and basic information;
- willing to participate in this study and sign an informed consent form.
You may not qualify if:
- Patients receiving neoadjuvant radiotherapy or chemotherapy;
- patients with other malignant tumors other than gastric cancer;
- patients with incomplete or unclear pathological data;
- individuals who are not willing to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dong Penglead
Study Sites (1)
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Biospecimen
surgically resected tissue and serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 25, 2025
First Posted
March 4, 2025
Study Start
December 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 4, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
Data sharing is not permitted by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University.